Astrazeneca PLC Sponsored ADR is a company in the U.S. stock market and it is a holding in 11 U.S.-traded ETFs. AZN has around 391.0K shares in the U.S. ETF market. The largest ETF holder of AZN is the VanEck Vectors Pharmaceutical ETF (PPH), with approximately 217.33K shares. Investors may also find of interest that the ETF with the largest allocation to AZN stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 5.00%. On average, U.S. ETFs allocate 1.91% of AZN to their portfolios.

Additionally, AZN is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AZN as a holding is the Loncar Cancer Immunotherapy ETF (CNCR), with a return of 45.72%.